Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of combination therapy with standard-dose carbapenem for treating nosocomial pneumonia caused by carbapenem-resistant Acinetobacter baumannii in intensive care units: A multicentre retrospective propensity score-matched study.
Wang SH, Yang KY, Sheu CC, Lin YC, Chan MC, Feng JY, Chen CM, Chen CY, Zheng ZR, Chou YC, Peng CK; T-CARE (Taiwan Critical Care and Infection) Group. Wang SH, et al. Among authors: zheng zr. Int J Antimicrob Agents. 2024 Jan;63(1):107044. doi: 10.1016/j.ijantimicag.2023.107044. Epub 2023 Nov 30. Int J Antimicrob Agents. 2024. PMID: 38040319
Efficacy of adjunctive nebulized colistin in critically ill patients with nosocomial carbapenem-resistant Gram-negative bacterial pneumonia: a multi-centre observational study.
Feng JY, Peng CK, Sheu CC, Lin YC, Chan MC, Wang SH, Chen CM, Shen YC, Zheng ZR, Lin YT, Yang KY; T-CARE (Taiwan Critical Care and Infection) Group. Feng JY, et al. Among authors: zheng zr. Clin Microbiol Infect. 2021 Oct;27(10):1465-1473. doi: 10.1016/j.cmi.2021.01.020. Epub 2021 Feb 1. Clin Microbiol Infect. 2021. PMID: 33540113 Free article.
Efficacies of Colistin-Carbapenem versus Colistin-Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study.
Wang SH, Yang KY, Sheu CC, Chen WC, Chan MC, Feng JY, Chen CM, Wu BR, Zheng ZR, Chou YC, Peng CK, On Behalf Of The T-Care Taiwan Critical Care Infection Group. Wang SH, et al. Among authors: zheng zr. Antibiotics (Basel). 2021 Sep 7;10(9):1081. doi: 10.3390/antibiotics10091081. Antibiotics (Basel). 2021. PMID: 34572663 Free PMC article.
The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study.
Wang SH, Yang KY, Sheu CC, Chen WC, Chan MC, Feng JY, Chen CM, Wu BR, Zheng ZR, Chou YC, Peng CK; T.-CARE (Taiwan Critical Care, Infection) Group. Wang SH, et al. Among authors: zheng zr. Crit Care. 2022 Apr 4;26(1):91. doi: 10.1186/s13054-022-03947-9. Crit Care. 2022. PMID: 35379303 Free PMC article.
Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study.
Chen CY, Yang KY, Peng CK, Sheu CC, Chan MC, Feng JY, Wang SH, Chen CM, Zheng ZR, Liang SJ, Lin YC; T-CARE (Taiwan Critical Care and Infection) Group. Chen CY, et al. Among authors: zheng zr. Sci Rep. 2022 May 7;12(1):7501. doi: 10.1038/s41598-022-11061-7. Sci Rep. 2022. PMID: 35525867 Free PMC article.
Clinical effectiveness of tigecycline in combination therapy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective multi-centre observational study.
Yang KY, Peng CK, Sheu CC, Lin YC, Chan MC, Wang SH, Chen CM, Chen CY, Zheng ZR, Feng JY; T-CARE (Taiwan Critical Care and Infection) Group. Yang KY, et al. Among authors: zheng zr. J Intensive Care. 2023 Jan 3;11(1):1. doi: 10.1186/s40560-022-00647-y. J Intensive Care. 2023. PMID: 36597165 Free PMC article.
Mortality and ventilator dependence in critically ill patients with ventilator-associated pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Kao HH, Peng CK, Sheu CC, Lin YC, Chan MC, Wang SH, Chen CM, Shen YC, Zheng ZR, Lin YT, Hsu HS, Feng JY, Yang KY; T-CARE (Taiwan Critical Care and Infection) Group. Kao HH, et al. Among authors: zheng zr. J Microbiol Immunol Infect. 2023 Aug;56(4):822-832. doi: 10.1016/j.jmii.2023.04.004. Epub 2023 Apr 27. J Microbiol Immunol Infect. 2023. PMID: 37149411 Free article.
Primary tumor consolidative therapy improves the outcomes of patients with advanced EGFR-mutant lung adenocarcinoma treated with first-line osimertinib.
Wu JJ, Tseng JS, Zheng ZR, Chu CH, Chen KC, Lin MW, Huang YH, Hsu KH, Yang TY, Yu SL, Chen JS, Ho CC, Chang GC. Wu JJ, et al. Among authors: zheng zr. Ther Adv Med Oncol. 2024 Jan 3;16:17588359231220606. doi: 10.1177/17588359231220606. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 38188463 Free PMC article.
61 results